Cyclohexyl GPR40 agonists for the treatment of type II diabetes
US10988433B2 · kind B2 · utility
0Cited by
1References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2017 |
| Grant date | Apr 27, 2021 |
| Priority date | — |
| Expiry date | Oct 24, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: wherein R1B, WB, LB, , and GB are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.